143 related articles for article (PubMed ID: 34894851)
1. Validation and adaptation of the Spanish version of the systemic lupus activity questionnaire (S-SLAQ) in an Argentinean population.
Catoggio C; Martínez Muñoz A; Chaparro Del Moral R; Klajn DS; Papasidero SB; Machado Escobar MA; Gonzalez Lucero L; Lucero E; Martinez L; Muñoz SA; Collado MV; Gomez GN; Sarano J; Marin J; Scolnik M; Romero J; Barreira JC; Zalazar MM; Rillo OL; Pisoni C
Lupus; 2021 Dec; 30(14):2230-2236. PubMed ID: 34894851
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Japanese version of the Systemic Lupus Activity Questionnaire that includes physician-based assessments in a large observational cohort.
Okamoto Y; Katsumata Y; Baba S; Kawaguchi Y; Gono T; Hanaoka M; Kawasumi H; Yamanaka H
Lupus; 2016 Apr; 25(5):486-95. PubMed ID: 26589578
[TBL] [Abstract][Full Text] [Related]
3. Validation and evaluation of the German version of the Systemic Lupus Activity Questionnaire (SLAQ).
Chehab G; Richter J; Sander O; Fischer-Betz R; Ostendorf B; Al-Neyadi T; Vordenbäumen S; Acar H; Brinks R; Schneider M
Clin Exp Rheumatol; 2015; 33(3):354-9. PubMed ID: 25797042
[TBL] [Abstract][Full Text] [Related]
4. Quick Systemic Lupus Activity Questionnaire (Q-SLAQ): a simplified version of SLAQ for patient-reported disease activity.
Svenungsson E; Gunnarsson I; Illescas-Bäckelin V; Trysberg E; Jönsen A; Leonard D; Sjöwall C; Pettersson S
Lupus Sci Med; 2021 May; 8(1):. PubMed ID: 33972457
[TBL] [Abstract][Full Text] [Related]
5. Translation, cultural adaptation and validation of the Systemic Lupus Erythematosus Activity Questionnaire (SLAQ) in a cohort of Italian systemic lupus erythematosus patients.
Tani C; Vagelli R; Stagnaro C; Carli L; Lorenzoni V; Drago F; Doherty W; McSorley MR; Marconcini L; Della Rossa A; Turchetti G; Mosca M
Lupus; 2018 Sep; 27(10):1735-1741. PubMed ID: 30045666
[TBL] [Abstract][Full Text] [Related]
6. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: a patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms.
Askanase AD; Castrejón I; Pincus T
J Rheumatol; 2011 Jul; 38(7):1309-16. PubMed ID: 21459938
[TBL] [Abstract][Full Text] [Related]
7. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies.
Karlson EW; Daltroy LH; Rivest C; Ramsey-Goldman R; Wright EA; Partridge AJ; Liang MH; Fortin PR
Lupus; 2003; 12(4):280-6. PubMed ID: 12729051
[TBL] [Abstract][Full Text] [Related]
8. A comparison of patients' and physicians' assessments of disease activity using the Swedish version of the Systemic Lupus Activity Questionnaire.
Pettersson S; Svenungsson E; Gustafsson J; Möller S; Gunnarsson I; Welin Henriksson E
Scand J Rheumatol; 2017 Nov; 46(6):474-483. PubMed ID: 28293972
[TBL] [Abstract][Full Text] [Related]
9. Clinical composite measures of disease activity and damage used to evaluate patients with systemic lupus erythematosus: A systematic literature review.
Castrejón I; Rúa-Figueroa I; Rosario MP; Carmona L
Reumatol Clin; 2014; 10(5):309-20. PubMed ID: 25022441
[TBL] [Abstract][Full Text] [Related]
10. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus.
Uribe AG; Vilá LM; McGwin G; Sanchez ML; Reveille JD; Alarcón GS
J Rheumatol; 2004 Oct; 31(10):1934-40. PubMed ID: 15468356
[TBL] [Abstract][Full Text] [Related]
11. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort.
Yazdany J; Yelin EH; Panopalis P; Trupin L; Julian L; Katz PP
Arthritis Rheum; 2008 Jan; 59(1):136-43. PubMed ID: 18163398
[TBL] [Abstract][Full Text] [Related]
12. The validity and reliability of Systemic Lupus Erythematosus Quality of Life Questionnaire (L-QoL) in a Turkish population.
Duruöz MT; Unal C; Toprak CS; Sezer I; Yilmaz F; Ulutatar F; Atagündüz P; Baklacioglu HS
Lupus; 2017 Dec; 26(14):1528-1533. PubMed ID: 28467289
[TBL] [Abstract][Full Text] [Related]
13. Validation of a disease-specific health-related quality of life measure in adult Italian patients with systemic lupus erythematosus: LupusQoL-IT.
Conti F; Perricone C; Reboldi G; Gawlicki M; Bartosiewicz I; Pacucci VA; Massaro L; Miranda F; Truglia S; Alessandri C; Spinelli FR; Teh LS; Ceccarelli F; Valesini G
Lupus; 2014 Jul; 23(8):743-51. PubMed ID: 24569393
[TBL] [Abstract][Full Text] [Related]
14. Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI).
Romero-Diaz J; Isenberg D; Ramsey-Goldman R
Arthritis Care Res (Hoboken); 2011 Nov; 63 Suppl 11(0 11):S37-46. PubMed ID: 22588757
[No Abstract] [Full Text] [Related]
15. Patient-reported outcome measures in systemic lupus erythematosus by a web-based application: A randomized, crossover, agreement study.
Uhrenholt L; Høstgaard S; Pedersen JF; Christensen R; Dreyer L; Leffers HCB; Taylor PC; Strand V; Jacobsen S; Voss A; Gregersen JW; Kristensen S
Lupus; 2021 Nov; 30(13):2124-2134. PubMed ID: 34719299
[TBL] [Abstract][Full Text] [Related]
16. Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.
Jesus D; Matos A; Henriques C; Zen M; Larosa M; Iaccarino L; Da Silva JAP; Doria A; Inês LS
Ann Rheum Dis; 2019 Mar; 78(3):365-371. PubMed ID: 30626657
[TBL] [Abstract][Full Text] [Related]
17. Validation of the Lupus Impact Tracker in an Australian patient cohort.
Antony A; Kandane-Rathnayake RK; Ko T; Boulos D; Hoi AY; Jolly M; Morand EF
Lupus; 2017 Jan; 26(1):98-105. PubMed ID: 27516435
[TBL] [Abstract][Full Text] [Related]
18. Turkish lupusPRO: cross-cultural validation study for lupus.
Kaya A; Goker B; Cura ES; Tezcan ME; Tufan A; Mercan R; Bitik B; Haznedaroglu S; Ozturk MA; Mikolaitis-Preuss RA; Block JA; Jolly M
Clin Rheumatol; 2014 Aug; 33(8):1079-84. PubMed ID: 23934384
[TBL] [Abstract][Full Text] [Related]
19. Reliability of the SF-36 in Japanese patients with systemic lupus erythematosus and its associations with disease activity and damage: a two-consecutive year prospective study.
Baba S; Katsumata Y; Okamoto Y; Kawaguchi Y; Hanaoka M; Kawasumi H; Yamanaka H
Lupus; 2018 Mar; 27(3):407-416. PubMed ID: 28795653
[TBL] [Abstract][Full Text] [Related]
20. The Perceived Stress Scale-10 (PSS-10) is reliable and has construct validity in Chinese patients with systemic lupus erythematosus.
Sun Y; Gao L; Kan Y; Shi BX
Lupus; 2019 Feb; 28(2):149-155. PubMed ID: 30518288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
